Latest Articles
-
Will Canadian Cannabis Producer Aphria Join The M&A Bandwagon?
Ever since the Canadian government was in talks to legalize adult-use of marijuana, pot stocks in the country have been on the rise. In the quest to capture the soon-to-open recreational marijuana market, top Canadian cannabis companies have been...
-
Could Smaller Pot Companies Be Targets After The Constellation – Canopy Deal?
Last week, beer and wine company Constellation Brands (NYSE: STZ) announced that it would be investing about $4 billion into marijuana producer, Canopy Growth Corporation, as it looks to get a head start in the market for cannabis-infused drinks....
-
Here’s Why We Believe Canadian Medical Cannabis Producer Aphria Is Worth CAD 12.60 Per Share
As the date for legalization of recreational marijuana in Canada nears, investors are closely watching every move made by the cannabis companies in the country. This is the reason why Canadian medical cannabis producer, Aphria, witnessed a sharp ...
-
Is Pot Stock Tilray Inc. Overvalued?
Tilray Inc. (NASDAQ: TLRY) became the first marijuana company to have an initial public offering on the U.S. stock exchange. While other marijuana companies are also listed on American exchanges, such as Cronos Group and Canopy Growth Corp., they...
-
Medical Marijuana Producer Aphria’s International Expansion Plans To Drive Its Value In The Long Term
With barely two months left for the much-awaited legalization of recreational marijuana in Canada, all the pot stocks in the country are aggressively preparing for the groundbreaking event and its after effects. However, given the uncertainty aro...
-
Why Did Philip Morris’ Shares Tumble Despite An Earnings Beat?
It was all about iQOS in Philip Morris International ‘s (NYSE:PM) second quarter results announcement, and, at least in the short term, it does not look good. While the company handily beat consensus estimates on both revenues and earnings...
-
Can Philip Morris Provide Some Positive iQOS News In The Second Quarter?
Philip Morris International (NYSE:PM) is set to release its second quarter earnings on July 19, wherein revenue and EPS growth of 9.4% and 8.8% are expected, as compared to the corresponding quarter of the previous year. Revenue growth is set to...
-
Restrictions On Packaging & Branding Could Hamper Canadian Cannabis Producer Canopy Growth’s Sales
Cannabis companies in Canada are actively preparing to meet the anticipated rise in the demand for cannabis products post October, when the country will legalize adult-use of marijuana for recreational purposes. On the one hand, these companies a...
-
Why A High Valuation For Aurora Cannabis Makes Sense
Pot stocks have been on a roll post a vote in the Canadian parliament on June 19 to legalize recreational use, which will come into effect in October of this year. Growth in their shares is reminiscent of the high returns seen in tobacco stocks s...
-
How Does Medical Cannabis Producer Canopy Growth Plan To Cater To The Newly Opened Recreational Marijuana Market
As Canada prepares to become one of the few developed nations to legalize adult-use of marijuana, prices of pot stocks in the country have been sky-rocketing over the past year. Given the vast opportunity that the passing of the Cannabis Act will...
-
What Will Drive The Growth For Cannabis Stock Cronos Group
Canadian cannabis stock Cronos Group (NASDAQ: CRON) (TOR: CRON.TO) has had a relatively mixed performance over the last few months, with its stock falling from over CAD 11 in early January to levels of about CAD 8.50 currently, due to relatively ...
-
Medical Marijuana Producer Canopy Growth – Undervalued Or Overvalued?
With all the excitement around legalization of marijuana for recreational purposes in Canada, pot stocks in the country are having a gala time. Investors are rushing to buy these stocks to generate early returns from the newly opened recreational...
-
Here’s Why Medical Marijuana Producer Aphria Could Become A Leader In The Recreational Marijuana Market
Canada will soon become one of the few countries to legalize adult-use of marijuana for recreational purposes. Consequently, Canadian cannabis stocks have witnessed a surge in their valuation lately. While the investors are optimistic about the u...
-
What Is Cronos Group Doing To Capitalize On Canada’s Legalization Of Marijuana?
Canada is moving closer to the legalizing the sale of marijuana for recreational purposes, with the country’s Senate recently voting in favor of new legislation. Canadian marijuana stocks have been soaring over the past year in anticipation of th...
-
What Is The Key Factor That Will Drive Medical Marijuana Producer Aphria’s Value Going Forward?
As Canada comes close to legalizing recreational marijuana, cannabis stocks have witnessed a sudden surge in their valuation. Despite the vast upside opportunity for pot stocks, the opening up of the recreational marijuana market may be faced wit...
